Dennis L. Bohn

Metabolism-Directed Optimization of 3-Aminopyrazinone Acetamide Thrombin Inhibitors. Development of an Orally Bioavailable Series Containing P1 and P3 Pyridines

Christopher S. Burgey, Kyle A. Robinson, Terry A. Lyle et al. · Journal of Medicinal Chemistry · 2003 · 121 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Discovery and Evaluation of Potent P₁ Aryl Heterocycle-Based Thrombin Inhibitors

Mary Beth Young, James C. Barrow, Kristen L. Glass et al. · Journal of Medicinal Chemistry · 2004 · 93 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Pharmacokinetic optimization of 3-amino-6-chloropyrazinone acetamide thrombin inhibitors. implementation of P3 pyridine N-Oxides to deliver an orally bioavailable series containing P1 N-Benzylamides

Christopher S. Burgey, Kyle A. Robinson, Terry A. Lyle et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 38 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Effects of mercurial diuretics on renal transport of urate in the chimpanzee

George M. Fanelli, Dennis L. Bohn, Sheila S. Reilly et al. · American Journal of Physiology-Legacy Content · 1973 · 32 citations

Pharmacy, Nephrology, Physiology +11

α-Hydroxy amides as a novel class of bradykinin B1 selective antagonists

Michael R. Wood, Kathy M. Schirripa, June J. Kim et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 27 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10